Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer.
lung cancer
non-small cell lung cancer
oligometastases
oligometastatic disease
stereotactic body radiotherapy
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
07
2019
accepted:
24
10
2019
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
5
12
2019
Statut:
epublish
Résumé
Metastatic non-small cell lung cancer (NSCLC) is associated with a limited survival when treated with palliative intent platinum-based chemotherapy alone. Recent advances in imaging and therapeutic strategy have identified a subset of patients with limited metastases who may benefit from early local ablative therapy with either surgery or radiotherapy, in addition to standard treatment. Stereotactic body radiotherapy (SBRT) is increasingly used in the treatment of extra-cranial oligometastatic NSCLC (OM-NSCLC) due its non-invasive conduct and ability to deliver high doses. Clinical evidence supporting the use of SBRT in OM-NSCLC is emerging and consistently demonstrates significant benefit in local control and progression-free survival. Here, we discuss the definition of oligometastases (OM), review current available data on SBRT treatment in extra-cranial OM-NSCLC including evidence for site-specific SBRT in lung, liver, and adrenal metastases.
Identifiants
pubmed: 31799188
doi: 10.3389/fonc.2019.01219
pmc: PMC6863405
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1219Informations de copyright
Copyright © 2019 Wujanto, Vellayappan, Siva, Louie, Guckenberger, Slotman, Onishi, Nagata, Liu and Lo.
Références
Ann Oncol. 2014 Oct;25(10):1954-9
pubmed: 25114022
Lancet. 2004 May 22;363(9422):1665-72
pubmed: 15158627
BMJ Open. 2018 Apr 17;8(4):e020690
pubmed: 29666135
Thorax. 2013 Jun;68(6):551-64
pubmed: 23399908
Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21
pubmed: 10493478
Nat Rev Clin Oncol. 2011 May 24;8(7):405-16
pubmed: 21606970
J Clin Oncol. 2009 Apr 1;27(10):1572-8
pubmed: 19255321
Lancet. 2019 May 18;393(10185):2051-2058
pubmed: 30982687
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
Lung Cancer. 2016 Jul;97:51-8
pubmed: 27237028
Radiat Oncol. 2014 Apr 02;9(1):91
pubmed: 24694067
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):880-7
pubmed: 24867533
Radiother Oncol. 2017 May;123(2):182-188
pubmed: 28169042
J Thorac Oncol. 2012 Oct;7(10):1547-55
pubmed: 22982655
Am J Clin Oncol. 2017 Aug;40(4):418-422
pubmed: 25647831
Acta Oncol. 2016 May;55(5):633-7
pubmed: 27046290
J Thorac Oncol. 2012 Feb;7(2):376-81
pubmed: 22198429
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):326-32
pubmed: 20117285
Cancer. 2012 Jun 1;118(11):2962-70
pubmed: 22020702
J Clin Oncol. 1995 Jan;13(1):8-10
pubmed: 7799047
JAMA Oncol. 2019 Jul 11;:
pubmed: 31294762
Technol Cancer Res Treat. 2013 Jun;12(3):217-24
pubmed: 23369155
Lancet Oncol. 2014 Apr;15(4):387-95
pubmed: 24621620
Nat Rev Clin Oncol. 2011 Jun;8(6):378-82
pubmed: 21423255
Front Oncol. 2017 Sep 19;7:210
pubmed: 28975081
Mol Clin Oncol. 2015 Jan;3(1):217-221
pubmed: 25469298
BMC Cancer. 2018 Mar 13;18(1):283
pubmed: 29534687
J Thorac Oncol. 2015 Nov;10(11):1515-22
pubmed: 26536193
Oncologist. 2008;13 Suppl 1:5-13
pubmed: 18263769
Lung Cancer. 2014 Oct;86(1):78-84
pubmed: 25130083
Strahlenther Onkol. 2011 Apr;187(4):245-51
pubmed: 21424513
Cancer. 2008 Feb 1;112(3):650-8
pubmed: 18072260
Am J Clin Oncol. 2011 Jun;34(3):249-53
pubmed: 20498589
Clin Lung Cancer. 2014 Sep;15(5):346-55
pubmed: 24894943
JAMA Oncol. 2018 Jan 11;4(1):e173501
pubmed: 28973074
Eur J Cardiothorac Surg. 2010 May;37(5):1198-204
pubmed: 20022516
Anticancer Res. 2017 Sep;37(9):5285-5291
pubmed: 28870966
Lancet Oncol. 2016 Dec;17(12):1672-1682
pubmed: 27789196
CA Cancer J Clin. 2009 May-Jun;59(3):145-70
pubmed: 19364702
Acta Chir Scand. 1951 Dec 13;102(4):316-9
pubmed: 14914373
Jpn J Clin Oncol. 2010 Feb;40(2):107-11
pubmed: 20047860
J Clin Oncol. 1991 Sep;9(9):1618-26
pubmed: 1651993
Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):511-520
pubmed: 27843031
Curr Oncol Rep. 2012 Aug;14(4):333-41
pubmed: 22535505
JAMA Oncol. 2019 Feb 1;5(2):243-247
pubmed: 30419088
Clin Oncol (R Coll Radiol). 2016 Jan;28(1):13-20
pubmed: 26385822
Jpn J Clin Oncol. 2010 Aug;40(8):788-94
pubmed: 20406944
Acta Oncol. 2009;48(4):578-83
pubmed: 19373699
J Clin Oncol. 2019 Jun 20;37(18):1558-1565
pubmed: 31067138
Radiother Oncol. 2013 Jun;107(3):409-13
pubmed: 23773410
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1399-1404
pubmed: 27319288